Envestnet Portfolio Solutions Inc. Sells 3,844 Shares of Agilent Technologies, Inc. (NYSE:A)

Envestnet Portfolio Solutions Inc. decreased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 11.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 30,606 shares of the medical research company’s stock after selling 3,844 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Agilent Technologies were worth $4,112,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Vestal Point Capital LP purchased a new position in Agilent Technologies during the 3rd quarter valued at about $14,848,000. Sienna Gestion grew its stake in Agilent Technologies by 29.8% during the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock valued at $10,537,000 after acquiring an additional 17,991 shares in the last quarter. S.E.E.D. Planning Group LLC increased its holdings in Agilent Technologies by 12.7% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock worth $5,721,000 after acquiring an additional 4,805 shares during the period. Sequoia Financial Advisors LLC lifted its stake in Agilent Technologies by 8.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock worth $4,554,000 after purchasing an additional 2,664 shares in the last quarter. Finally, Miracle Mile Advisors LLC bought a new position in Agilent Technologies in the 4th quarter valued at $362,000.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on A. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. JPMorgan Chase & Co. decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Sanford C. Bernstein dropped their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Bank of America decreased their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Finally, Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $146.15.

Agilent Technologies Trading Up 0.5 %

NYSE A opened at $123.10 on Wednesday. The firm has a market cap of $35.09 billion, a PE ratio of 28.30, a price-to-earnings-growth ratio of 3.40 and a beta of 1.11. Agilent Technologies, Inc. has a 1-year low of $117.17 and a 1-year high of $155.35. The stock has a 50-day moving average of $137.70 and a 200-day moving average of $137.68. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.81%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.